SuperworthVor Biopharma market cap VOR
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Oct 23, 2026
- $1.1B
- Highest close in our data
- $1.5B
- Sep 2026
Vor Biopharma is worth $1.1B at the close on Oct 23, 2026, at $18.26 a share.
That is up 527% over the last year and up 85% over five years.
Its highest close in our data was $1.5B in Sep 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $1.1B | $121.2M | $1.5B | +605% |
| 2025 | $153.2M | $18.9M | $312.4M | +76% |
| 2024 | $87.2M | $45.8M | $166.8M | −43% |
| 2023 | $152.6M | $119.3M | $390.3M | −41% |
| 2022 | $257.1M | $145M | $394.5M | −41% |
| 2021 | $433.3M | $433.3M | $910.8M | n/a |
Against its peers
Companies in Biotechnology nearest Vor Biopharma's size, closest first, today.
| Company | Market cap |
|---|---|
| VORVor Biopharma | $1.1B |
| MGTXMeiraGTx | $884.6M |
| VCELVericel | $2.2B |
| ADMAAdma Biologics | $2.4B |
| PLXProtalix BioTherapeutics | $205.5M |
| KRYSKrystal Biotech | $9.2B |
| RGENRepligen | $10B |
| Peer median | $2.3B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Vor Biopharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.